US Patent 10214579 Fc fusion proteins comprising novel linkers or arrangements
Patent 10214579 was granted and assigned to Bristol-Myers Squibb on February, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 4 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+369 characters)
Article
Patent abstract
The application provides Fc fusion proteins having novel arrangements. In one embodiment, the application provides Fc fusion proteins comprising a 10F3 domain. In another embodiment, the application provides Fc fusion proteins comprising linkers derived from the naturally occurring C-terminal tail regions of membrane bound or secretory immunoglobulins.
Edits on 29 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
102145790
Date of Patent
February 26, 2019
0Patent Application Number
152571890
Date Filed
September 6, 2016
0Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
102145790
Date of Patent
February 26, 2019
0Patent Application Number
152571890
Date Filed
September 6, 2016
0Patent Primary Examiner
Edits on 25 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10214579 Fc fusion proteins comprising novel linkers or arrangements
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10214579
Date of patent
February 26, 2019
Patent application number
15257189
Date Filed
September 6, 2016
Patent primary examiner
Find more entities like US Patent 10214579 Fc fusion proteins comprising novel linkers or arrangements
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
